Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CHIEF TECHNICAL OFFICER

CHIEF EXECUTIVE OFFICER

CHIEF MEDICAL OFFICER

SEE REMARKS

CHIEF SCIENTIFIC OFFICER

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of pat...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-02	Premium	sold	Premium	Premium	Premium	CHIEF TECHNICAL OFFICER
2024-05-01	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-05-01	Premium	sold	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-04-17	Premium	sold	Premium	Premium	Premium	CHIEF MEDICAL OFFICER
2024-04-17	Premium	acquired	Premium	Premium	Premium	CHIEF MEDICAL OFFICER
2024-04-17	Premium	acquired	Premium	Premium	Premium	SEE REMARKS
2024-04-17	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2024-04-16	Premium	sold	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-04-16	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-04-10	Premium	acquired	Premium	Premium	Premium	SEE REMARKS
2024-04-10	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2024-04-09	Premium	sold	Premium	Premium	Premium	-
2024-04-01	Premium	acquired	Premium	Premium	Premium	CHIEF TECHNICAL OFFICER
2024-04-01	Premium	sold	Premium	Premium	Premium	CHIEF TECHNICAL OFFICER
2024-04-01	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2024-04-01	Premium	sold	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-04-01	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2024-04-01	Premium	acquired	Premium	Premium	Premium	SEE REMARKS
2024-04-01	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-04-01	Premium	acquired	Premium	Premium	Premium	SEE REMARKS
2024-03-28	Premium	acquired	Premium	Premium	Premium	CHIEF MEDICAL OFFICER
2024-03-28	Premium	sold	Premium	Premium	Premium	CHIEF MEDICAL OFFICER
2024-03-27	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2024-03-27	Premium	acquired	Premium	Premium	Premium	SEE REMARKS
2024-03-25	Premium	acquired	Premium	Premium	Premium	SEE REMARKS

AVTE - Aerovate Therapeutics, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for AVTE